Use of Mouse Models in Atherosclerosis Research

Area of Science:

• Cardiovascular research
• Immunology
• Genetics

Background:

• Cardiovascular disease (CVD) is a leading cause of mortality globally.
• Atherosclerosis is the primary pathology underlying major CVDs like myocardial infarction and stroke.
• Understanding atherosclerosis mechanisms is vital for developing effective treatments.

Purpose of the Study:

• To review genetically modified mouse models for atherosclerosis research.
• To examine the progression and regression of atherosclerosis in these models.
• To elucidate the role of immune cells and genetic factors in atherogenesis.

Main Methods:

• Utilizing genetically modified mouse models, specifically those deficient in apoprotein E or LDL receptor.
• Analyzing atherosclerosis progression and regression dynamics.
• Investigating the contribution of immune cell populations to disease development.
• Examining the genetic underpinnings of murine atherogenesis.

Main Results:

• Genetically modified mice provide valuable insights into atherosclerosis mechanisms.
• These models facilitate the study of disease progression and potential regression strategies.
• Immune cell involvement and genetic factors significantly influence atherogenesis in mice.

Conclusions:

• Genetically modified mouse models are indispensable tools for preclinical atherosclerosis research.
• Further investigation into immune cell roles and genetic influences can advance our understanding of CVD.
• These models hold promise for developing novel therapeutic interventions for atherosclerosis.